Venture Visionary Partners LLC Purple Biotech Ltd. Transaction History

Venture Visionary Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.41 - $0.86 $2,709 - $5,682	6,608 Added 42.49%	22,161 $9,000
Q4 2023 Jan 24, 2024	BUY	$0.78 - $1.67 $772 - $1,654	991 Added 6.81%	15,553 $12,000
Q3 2023 Oct 13, 2023	BUY	$1.02 - $1.49 $860 - $1,257	844 Added 6.15%	14,562 $17,000
Q2 2023 Jul 14, 2023	BUY	$1.38 - $2.05 $896 - $1,332	650 Added 4.97%	13,718 $19,000
Q2 2022 Jul 26, 2022	BUY	$2.39 - $4.15 $4,780 - $8,300	2,000 Added 18.07%	13,068 $31,000
Q4 2021 Feb 08, 2022	BUY	$3.75 - $4.67 $3,750 - $4,670	1,000 Added 9.93%	11,068 $43,000
Q3 2021 Oct 20, 2021	BUY	$4.4 - $5.59 $44,299 - $56,280	10,068 New	10,068 $46,000

19.3K

Ticker PPBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,303,300
Market Cap $46.5M
Description
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...

Get notified when there are updates to the investment portfolio of Venture Visionary Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Venture Visionary Partners LLC with notifications on news.